Who to call at OXB, and when
Fundz watches for the moments OXB starts buying, and tells you who to reach.
- An alert the day OXB raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at OXB, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at OXB. With Fundz connected, it knows.
OXB and Aura Biosciences form partnership to support Phase 3 development of oncology candidate.
Contract Type
partnership
Description
OXB has confirmed a partnership with Aura Biosciences aimed at supporting the Phase 3 development of its lead oncology candidate. This collaboration also includes provisions for future commercial supply, enhancing OXB's capabilities in oncology treatments.
Quick answer
OXB and Aura Biosciences form partnership to support Phase 3 development of oncology candidate. (November 17, 2026).
- What agreement did OXB announce on November 17, 2026?
- OXB has confirmed a partnership with Aura Biosciences aimed at supporting the Phase 3 development of its lead oncology candidate. This collaboration also includes provisions for future commercial supply, enhancing OXB's capabilities in oncology treatments.
- What does OXB do?
- OXB is a biopharmaceutical company dedicated to advancing the development of innovative therapies.
- Which similar companies announced agreements around the same time?
- Sino Biopharmaceutical (November 13, 2026), AbbVie Inc. (November 3, 2026), AstraZeneca Pharma India (November 17, 2026) and Pfizer (November 14, 2026) also announced agreements within 45 days of OXB.
Source: Fundz verified event record.
Other recent agreements in Therapeutics and Biopharma
Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.
- Sino Biopharmaceutical Partners with Boehringer Ingelheim in a $358 Million Oncology Deal (November 13, 2026)
- AbbVie partners with McLaren Racing in a multiyear collaboration to promote liver health awareness through Formula 1. (November 3, 2026)
- AstraZeneca Pharma India Forms Partnership with Strand Life Sciences for Healthcare Collaboration. (November 17, 2026)
- Pfizer Partners with Blackstone Life Sciences to Co-Fund $1.5 Billion Development for Berobenatide Obesity Drug. (November 14, 2026)
- Teva and Samsung Bioepis Sign Agreement for U.S. Rights to Biosimilars Infliximab and Etanercept. (November 3, 2026)
- Rhode Island Life Science Hub and Cognito Therapeutics launch partnership for Alzheimer's research. (October 27, 2026)
Agreement Insights
What this usually meansOXB signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.